Sarah H. Plummer
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Mosquito-borne diseases and control, Malaria Research and Control, Viral Infections and Vectors, HIV Research and Treatment, Viral Infections and Outbreaks Research
Most-Cited Works
- → Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine(2013)772 cited
- → Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection(2015)468 cited
- → Protection against malaria at 1 year and immune correlates following PfSPZ vaccination(2016)374 cited
- → Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials(2017)300 cited
- → Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection(2017)251 cited
- → Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults(2015)251 cited
- → Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults(2018)251 cited
- → Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial(2014)248 cited
- → Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial(2014)131 cited
- → Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study(2019)125 cited